Navigation Links
The American Federation for Medical Research Unites Top Leaders to Mitigate U.S. Crisis in Clinical Research
Date:4/14/2009

WASHINGTON, Apr. 14 /PRNewswire/ -- The American Federation for Medical Research (AFMR) today has brought together several leaders from the public and private sectors to take action against the crisis in U.S. clinical research. This symposium marks the first time that major U.S. government agencies, corporations and leading academic institutions have united to address the issues that have prevented clinical research from advancing in America. This lack of advancement is part of the reason why the quality of the U.S. health care system has deteriorated. Until a higher priority is placed on clinical research and the most crippling issues are mitigated, it will be difficult to achieve sustainable change in the U.S. health care system, and the quality of health care delivered in the U.S. will continue to trail other nations.

"Medical science and the U.S. health care system cannot progress without clinical research," said Dr. Alan Buchman, president of the AFMR and a prominent physician in gastroenterology. "Yet our nation has neglected the advancement of patient-oriented clinical research, which can prevent disease, lead to more effective disease treatments, medical breakthroughs for chronic diseases, and cut the astronomical costs and inefficiencies that plague our health care system. These leaders have the potential to influence the advancement of clinical research, which will have an enormous positive ripple effect on the rest of the health care system," said Buchman.

Clinical research has not advanced in recent years due to:

  1. A loss of physician investigators and failure to educate, train and retain enough new clinicians in the techniques of clinical investigation for future generations of Americans. In addition, the current generation of physician investigators is aging rapidly and there are not enough investigators to replace them because support for new investigators entering the field has decreased significantly in recent years.
  2. Investigator educational programs are insufficient and under-funded. Federal budget cuts to research programs funded by the National Institutes of Health (NIH) are a root cause of this deficiency.
  3. An over-reliance on the pharmaceutical industry to conduct our nation's clinical research. This sector simply cannot fulfill our nation's clinical research needs -- nor is it the responsibility of the pharmaceutical industry to discover the natural history of disease and all of its modifiers.
  4. The U.S. infrastructure for clinical research has eroded and shifted largely to China and India, along with the jobs and revenue associated with such research.

*NOTE: The AFMR is available to all journalists seeking to better understand the issues surrounding clinical research. For an in-depth interview with American Federation for Medical Research President Dr. Alan Buchman, please contact Gwen Knapp at 502-265-0216 and visit the AFMR web site at www.afmr.org.

    CONTACT:
    Gwendolyn Knapp
    TOP SHELF Communications & Public Relations
    901-229-0416
    gknapp@topshelfpr.com


'/>"/>
SOURCE American Federation for Medical Research
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Many Older Americans Have Active Sex Lives
2. Despite grumbling, most Americans say they are happy at work
3. Record Number of Americans Lack Health Insurance
4. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
5. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
6. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
7. Novo Nordisk Appoints New Leader of North American Business
8. Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows
9. Primary biliary cirrhosis more severe in African-American and Hispanic patients
10. AOA President Calls on Congress to Reauthorize SCHIP and Take Action to Ensure Health Care Coverage for All Americans
11. American Chemical Societys Weekly Presspac -- Sept. 5, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 27, 2016 , ... More than a third of American adults are considered ... surgery has received increased attention in recent years, as an article published ... weight loss, most people are familiar with the basic requirements of maintaining a healthy ...
(Date:5/27/2016)... ... ... With over 60 percent of acute stroke survivors being left unable to ... in the rehabilitation process has steadily increased. Ekso Bionics had been working to help ... stroke. , Ekso Bionics has now received clearance from the U.S. Food and Drug ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed ... by inspiring human interest stories, courtesy of leaders in the nursing and health ... the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , Jones ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research commissioned ... dogs straight off the grill. Of the 90 percent of Americans who say they ... hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving (9 ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Connor Sports, ... basketball as a partner for the Tamika Catchings Legacy Tour that will ... industry leader in hardwood basketball surfaces in all forms and levels of the game, ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment ... "High doses of biotin in progressive multiple sclerosis: extension phase ... Ayman Tourbah , Principal Investigator of the Phase 3 ... Neurology (EAN) in Copenhagen, Denmark . The ... on Sunday, 29 May 2016 from 14:45 to 16:15 CEST ...
(Date:5/24/2016)... --   , ... Endpunkte und demonstriert Ebenbürtigkeit bei der Gesamtreinigung des ... guter , Reinigung des ... (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) , ... der MORA-Studie der Phase III für NER1006 (1 ...
(Date:5/24/2016)... Celsion Corporation (NASDAQ: CLSN ... an update on its ongoing OVATION study, a ... the Company,s DNA-based immunotherapy, with the standard of ... advanced ovarian cancer who will undergo neoadjuvant chemotherapy ... IL-12 DNA plasmid vector formulated as a nanoparticle ...
Breaking Medicine Technology: